ALLK Insider Trading Activity and SEC Form 4 Filings
ALLK insider trading summary
No open-market insider purchases or sales of Allakos Inc. (ALLK) have been reported on SEC Form 4 in the past 12 months.
Latest ALLK insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Jun 28, 2024 | Harlan Baird Radford | Chief Financial Officer | Sell | $88K (87,064 @ $1.01) |
| Sep 21, 2022 | Paul Edward Walker | Director | Buy | $3.0M (597,600 @ $5.02) |
| Sep 21, 2022 | Paul Edward Walker | Director | Buy | $17.0M (3,386,400 @ $5.02) |
| Sep 21, 2022 | Daniel Janney | Director | Buy | $2.4M (475,000 @ $5.02) |
| Sep 28, 2021 | Steven P James | Director | Sell | $432K (4,000 @ $108.12) |
| Jun 15, 2021 | Adam Tomasi | President and COO | Sell | $1.8M (20,000 @ $91.03) |
| Jun 14, 2021 | Adam Tomasi | President and COO | Sell | $1.8M (20,000 @ $91.62) |
| Jun 7, 2021 | Adam Tomasi | President and COO | Sell | $229K (2,487 @ $92.03) |
| Jun 4, 2021 | Robert Alexander | Chief Executive Officer | Sell | $1.3M (14,516 @ $89.64) |
| Jun 4, 2021 | Henrik S Md Rasmussen | Chief Medical Officer | Sell | $218K (2,435 @ $89.60) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.